This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment
BMC Cancer Open Access 30 May 2015
-
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression
Cell Division Open Access 18 October 2006
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Malumbres M, Barbacid M . To cycle or not to cycle: a critical decision in cancer. Nat Cancer Rev 2001; 1: 222–231.
Kuehl WM, Bergsagel PL . Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002; 2: 175–187.
Chim CS, Liang R, Tam C, Kwong YL . P15 and P16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 2001; 19: 2033–2040.
Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC, Huang DP . Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 1997; 89: 2500–2506.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA . Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756.
Mateos MV, Garcia-Sanz R, Lopez-Perez R, Balanzategui A, Gonzalez MI, Fernandez-Calvo J et al. P16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies. Hematol J 2001; 2: 146–149.
Kulkarni MS, Daggett JL, Bender TP, Kuehl WM, Bergsagel PL, Williams ME . Frequent inactivation of the cyclin dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Leukemia 2002; 16: 127–134.
Fonseca R, Harrington D, Oken MM, Dewald GW, Bailey RJ, Van Wier SA et al. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. Cancer Res 2002; 62: 715–720.
Acknowledgements
We thank Professor Eshhar, Department of Immunology, Weizmann Institute of Science, Israel, for provision of AF10 cell line; and Department of Pathology, Queen Mary Hospital, for the diagnoses; and Kadoorie Foundation for the funding support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chim, C., Fung, T. & Liang, R. Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS. Leukemia 17, 2533–2535 (2003). https://doi.org/10.1038/sj.leu.2403133
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403133
This article is cited by
-
The mechanistic role of epigenetic in multiple myeloma
Comparative Clinical Pathology (2016)
-
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment
BMC Cancer (2015)
-
piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma
Leukemia (2015)
-
Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma
Tumor Biology (2015)
-
Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets
Annals of Hematology (2011)